Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$205K Hold
5,644
0.46% 30
2023
Q2
$201K Sell
5,644
-52
-0.9% -$1.86K 0.18% 35
2023
Q1
$203K Hold
5,696
0.29% 30
2022
Q4
$200K Buy
5,696
+5,320
+1,415% +$177K 0.73% 27
2022
Q3
$11 Hold
376
0.04% 187
2022
Q2
$20K Hold
376
0.03% 127
2022
Q1
$20K Hold
376
0.03% 126
2021
Q4
$21K Hold
376
0.02% 134
2021
Q3
$18K Hold
376
0.01% 147
2021
Q2
$19K Hold
376
0.02% 136
2021
Q1
$17K Hold
376
0.02% 133
2020
Q4
$17K Buy
+376
New +$17.3K 0.02% 144

Other funds holding GSK

Johnson Midwest Financial's GSK Position: Q3 2023 in Review

Johnson Midwest Financial held its GSK (GSK) position steady in Q3 2023 at 5,644 shares worth $205K. The position accounts for 0.46% of the portfolio, ranked #30.

Johnson Midwest Financial first reported a position in GSK in Q4 2020 and has held it in 12 quarters since. 846 funds tracked by Wall St. Rank hold GSK as of Q3 2023.

  • Johnson Midwest Financial held 5,644 shares of GSK worth $205K as of Q3 2023.
  • Johnson Midwest Financial left its GSK share count unchanged in Q3 2023.
  • GSK made up 0.46% of Johnson Midwest Financial's portfolio in Q3 2023, its #30 holding.
  • Johnson Midwest Financial first reported a position in GSK in Q4 2020 and has held it in 12 quarters since.
  • 846 funds tracked by Wall St. Rank held GSK as of Q3 2023.

Based on Johnson Midwest Financial's 13F filing for Q3 2023, filed 7 Nov 2023.